← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Revenue increased 8.5% to $755.2M, while Net income increased 84.6% to ($1.9M).
The read at a glance✓ Audited against SEC data
- Scale — FY2025 revenue $755.2MWatch
- Profitability — Net income ($1.9M)Watch
- Cash generation — Free cash flow $58.8MOK
- Accounting — Formula-grey distress score · manipulation and earnings-quality screens not computedNote
- Insiders — 1 buys; 1 sells in 365 daysOK
- Capital — dividends paid were $20.6M; share repurchases were $25.4MNote
Business
Marcus & Millichap, Inc.: We are the leading national investment brokerage company in the $1 million to $10 million private client market.
Where the revenue comes from
Fiscal 2025, as Marcus & Millichap, Inc. reports it. History and quarterly detail are in the app.
- Real estate brokerage commissions$632.5M
- Financing fees$103.9M
- Other revenue$18.7M
Leadership changes
From Marcus & Millichap, Inc.'s own filings, the day they're filed.
- Richard Matricaria · Chief Operating Officer · appointmenteff. 2025-05-01
- John David Parker · Chief Operating Officer · appointmenteff. 2025-04-29
- Fabrice De Bossch · Chief Accounting Officer · appointmenteff. 2025-03-25
Latest filings
- 8-K · Company announcement2026-08-06
- 10-Q · Quarterly report2026-08-06
- 10-Q · Quarterly report2026-05-07
- 8-K · Company announcement2026-05-07
- 8-K · Company announcement2026-05-01
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Marcus & Millichap, Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.